ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679266; 2) Community: the network communities that were significantly associated with the response to NSC 679266; 3) Molecule: the relationships between components within communities and NSC 679266; 4) MDR: the compounds that were significantly associated with the NSC 679266.

NSC Compound Enrichment Correlation
NSC 295499 Camptothecin Derivative 0.00578566967432527 0.33434181
NSC 678088 Null 0.00578566967432527 0.46182422
NSC 692303 2,3-Dihydro-3(R)-[4'hydroxyphenylsulfinyl]brefeldin A 0.00640068043275774 -0.052476992
NSC 696073 Null 0.00640068043275774 0.093778931
NSC 9594 Safranin bluish 0.00640068043275774 -0.029434637
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.00640068043275779 0.30368588
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.00640068043275779 -0.042986571
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.00640068043275779 0.23227248
NSC 642311 Null 0.00640068043275779 0.16191365
NSC 643248 23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2 0.00640068043275779 0.30756061
Total:57  Current:7    [First] [Prev] [Next] [Last]